Moderna, Inc. (MRNA)

NASDAQ

$223.31

-$8.13

(-3.51%)

Previous Close: ⁦$231.35⁩

Market Closed

Moderna, Inc. (MRNA) Live Price Chart

Last updated: ⁦2026-11-15 04:00:01⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Moderna, Inc. (MRNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $223.31, with a market capitalization of $93.61B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $22.28 to $280.80. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$93.61B
Open	$224.90
Day's High	$232.23
Day's Low	$221.90
Previous Close	$231.35
Volume	6.95M
Average Volume	22.34M
P/E Ratio	--
52-Week High	$280.80
52-Week Low	$22.28
Dividend Yield	--
Earnings Date	12-31

Moderna, Inc. (MRNA) Latest Closing Stock Price

Moderna, Inc. (MRNA) last closed at $223.31 as of 2026-11-14 01:00:00, down 3.51% ($8.13) from the previous close of $231.35.

During the latest regular trading session, MRNA traded between $221.90 and $232.23, with a volume of 6.95M shares. The closing price was near the lower end and near the upper end of its 52-week range.

Moderna, Inc. (MRNA) 7-Day Stock Price Change

Over the past seven days, Moderna, Inc. (MRNA) moved from $241.46 to $223.31, representing a decline of 7.52% ($18.15).

The stock traded between $221.70 and $280.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 10.65 million shares, down versus the previous seven-day period, indicating lower trading activity.

MRNA 52-Week Price Position

Position in Range: 77.8%

52W Low$22.28

52W High$280.80

MRNA is currently trading at $223.31, placing it 77.8% of the way from its 52-week low of $22.28 to its 52-week high of $280.80. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Moderna, Inc. (MRNA)?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	4,700
CEO	Stéphane Bancel
Founded	2010
Exchange	NASDAQ
Company Website	https://www.modernatx.com

MRNA News

Latest news related to Moderna, Inc. and MRNA stock.

Massive2026/11/14
Axsome Therapeutics vs. Moderna: Which Biotech Innovator Stock Is a Better Buy for 2027?
Axsome Therapeutics and Moderna represent different biotech investment profiles. Axsome shows strong 54% revenue growth with three marketed drugs and a narrowing path to profitability, trading at conservative valuations (41x forward P/E). Moderna, despite its revolutionary mRNA platform, faces declining COVID vaccine demand and significant losses ($2.8B net loss on $2.5B revenue), trading at a premium 249x forward P/E. The article recommends Axsome as the better 2027 buy due to superior valuation and near-term revenue visibility, while acknowledging Moderna's long-term potential.
Read Full Article
Massive2026/11/12
MRNA Stock Up 3% Since Q3 Earnings Release: How to Play the Stock?
Moderna shares gained 3% following better-than-expected Q3 2026 earnings and raised full-year revenue guidance to 15-25% growth, driven by stronger international COVID-19 vaccine sales. The company's oncology pipeline, particularly its personalized cancer therapy intismeran developed with Merck, showed promising phase III results with a 42% reduction in recurrence or death risk. Despite premium valuation and ongoing cash burn concerns, Moderna maintains a Zacks Rank #2 (Buy) rating, supported by expanding respiratory vaccine portfolio and oncology opportunities.
Read Full Article
Benzinga2026/11/12
Moderna Analyst Day: Details Strategic Shift Toward Oncology and Enhanced Production Capabilities
Moderna raises its 2026 revenue forecast to 15%-25% and accelerates oncology investments, expanding its mRNA platform into new therapies.
Read Full Article
Benzinga2026/11/12
Moderna Raises FY26 Sales Growth Guidance To 15%-25% From 10%; On Track To Achieve FY26 Gross Margin Expansion Of ~10 Percentage Points Excluding Litigation Settlement Charge; Expects Annual Cash Costs Of ~$4B-$4.5B Over 2027-2030; Sees Ending 2026 With ~$9B In Total Liquidity, Including Cash, Investments And Undrawn Borrowing Capacity
Moderna, Inc. (NASDAQ:MRNA) today outlined the next phase of growth at its 2026 Analyst Day, highlighting how more than a decade of investment in the Company's mRNA platform has enabled the development of multiple
Read Full Article
Massive2026/11/11
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?
RSPH, an equal-weight healthcare ETF managed by Invesco, has delivered strong year-to-date returns of 30.11% and 12-month returns of 36.18% as of November 11, 2026. With $1.04 billion in assets and a 0.40% expense ratio, it provides diversified exposure to 64 healthcare holdings. However, investors seeking lower-cost alternatives may consider VHT (0.09% expense ratio) or XLV (0.08% expense ratio), which track traditional market-cap weighted healthcare indexes.
Read Full Article

Ways to Trade MRNA at MEXC

MRNA MEXC RealStocks

Own real MRNA shares through MEXC's regulated brokerage partner.

Suitable for long-term holding.

Own the actual shares
Receive dividends and voting rights
Buy fractional shares starting at $1

MRNA Tokenized Stocks

Get MRNA price exposure through a blockchain-based token.

Suitable for trading outside U.S. market hours.

Token tracks the MRNA price
Trade 24/7
Trade on weekends and holidays

MRNA Stock Futures

Trade MRNA price movements with futures contracts.

Suitable for short-term positions.

Go long or short
Trade 24/7
Up to 20x leverage

How to Buy Moderna, Inc. (MRNA) Stock on MEXC

Eligible investors can buy real shares of Moderna, Inc. (MRNA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MRNA and Place Your Order

Open the RealStocks trading page and search for MRNA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Moderna, Inc. (MRNA) stock price today?

Moderna, Inc. (MRNA) is currently trading at $223.31, down 3.51% ($8.13) from the previous close of $231.35. Intraday prices update in real time during regular trading hours.

2.Is MRNA stock going up or down today?

As of 2026-11-14 01:00:00, MRNA is trading at $223.31, down 3.51% ($8.13) from its previous close of $231.35. The stock has traded between $221.90 and $232.23 during today’s regular session. Past price movements do not guarantee future results.

3.What is MRNA pre-market price?

As of 2026-11-14 01:00:00, MRNA is trading at $226.10 in pre-market trading, down 2.27% ($5.25) from the previous close of $231.35. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MRNA after-hours price?

As of 2026-11-14 01:00:00, MRNA is trading at $217.50 in after-hours trading, down 2.60% ($5.81) from the regular-session close of $223.31. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MRNA stock trading now?

MRNA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MRNA sit relative to its 52-week high and low?

Over the past 52 weeks, MRNA has traded between a low of $22.28 and a high of $280.80. At $223.31, the stock is positioned 77.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Moderna, Inc. in?

Moderna, Inc. (MRNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Moderna, Inc.'s market capitalization and where is it listed?

Moderna, Inc. is listed on the NASDAQ exchange with a market capitalization of $93.61B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MRNA valued in terms of P/E ratio and EPS?

MRNA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-7.79. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Moderna, Inc. pay a dividend?

Moderna, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Moderna, Inc.

PFE

JNJ

AZN

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top Gainers

Browse today's leading gainers in the US stock market

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to MRNA, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Every Pull Wins！

Up to $10,000 in rewards & up to $3,000 in cashback!

Search Stocks

Popular

NVDA MSFT GOOGL GOOG AMZN

MRNA Stock Calculator

Estimate the value between MRNA shares and USD.

MRNA Shares to USD

MRNA Shares

MRNA

USD

1.00 MRNA shares = 223.312 USD

Calculations are estimates based on the latest available price and are for reference only.

Moderna, Inc. (MRNA)

Summary

Key Market Data

Moderna, Inc. (MRNA) Latest Closing Stock Price

Moderna, Inc. (MRNA) 7-Day Stock Price Change

MRNA 52-Week Price Position

What is Moderna, Inc. (MRNA)?

Moderna, Inc. Information

MRNA News

Axsome Therapeutics vs. Moderna: Which Biotech Innovator Stock Is a Better Buy for 2027?

MRNA Stock Up 3% Since Q3 Earnings Release: How to Play the Stock?

Moderna Analyst Day: Details Strategic Shift Toward Oncology and Enhanced Production Capabilities

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

Ways to Trade MRNA at MEXC

MRNA MEXC RealStocks

MRNA Tokenized Stocks

MRNA Stock Futures

How to Buy Moderna, Inc. (MRNA) Stock on MEXC

Frequently Asked Questions (FAQ)

Explore More US Stocks

Stocks in the Same Sector

Largest Market Cap

Most Actively Traded

Top Gainers

Top 5 Cryptocurrencies

Compliance Disclosure and Data Source

Disclaimer

Search Stocks

MRNA Stock Calculator